Emerging Therapeutic Options in Pancreatic Cancer Management-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging Therapeutic Options in Pancreatic Cancer Management

Published:2024-02-05 Issue:3 Volume:25 Page:1929
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Delle Cave Donatella¹^ORCID

Affiliation:

1. Institute of Genetics and Biophysics ‘Adriano Buzzati-Traverso’, CNR, 80131 Naples, Italy

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a 5-year survival rate of <8% [...]

Funder

Fondazione Umberto Veronesi

Fondazione Italiana per la ricerca sulle Malattie del Pancreas

Publisher

MDPI AG

Link

https://www.mdpi.com/1422-0067/25/3/1929/pdf

Reference47 articles.

1. Pancreatic Ductal Adenocarcinoma: Treatment Hurdles, Tumor Microenvironment and Immunotherapy;Sarantis;World J. Gastrointest. Oncol.,2020

2. Arnold, M., Abnet, C.C., Neale, R.E., Vignat, J., Giovannucci, E.L., McGlynn, K.A., and Bray, F. (2020). Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology, 159.

3. Translational Advances in Pancreatic Ductal Adenocarcinoma Therapy;Hosein;Nat. Cancer,2022

4. Pancreatic Cancer Stroma: An Update on Therapeutic Targeting Strategies;Hosein;Nat. Rev. Gastroenterol. Hepatol.,2020

5. Targeting the Tumour Stroma to Improve Cancer Therapy;Valkenburg;Nat. Rev. Clin. Oncol.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP